BMS-641988 (AR#2)
CA185-005
Phase 1 small_molecule completed
Quick answer
BMS-641988 (AR#2) for Prostate Cancer is a Phase 1 program (small_molecule) at Bristol-Myers Squibb with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Bristol-Myers Squibb
- Indication
- Prostate Cancer
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed